Analyst firms · BTIG · NUVB
BTIG NUVB price target and rating history
Nuvation Bio Inc. (NUVB) · Health Care
BTIG rates Nuvation Bio Inc. (NUVB) Buy with a $5 price target, as of its latest action on Mar 26, 2024. It has published 3 rating actions on NUVB since October 2021, including 1 upgrade and 1 downgrade.
- Current rating
- Buy
- Price target
- $5
- Median target, all firms
- Too few
- Actions on NUVB
- 3
BTIG price target on NUVB
Every BTIG rating on NUVB
- Mar 26, 2024
- Aug 2, 2022DowngradeBTIG downgrades to Neutral from Buy
- Oct 15, 2021
How other firms rate NUVB
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Citigroup | Buy | $12 | Sep 30, 2026 |
| Cantor Fitzgerald | Overweight | Aug 21, 2026 | |
| Truist Securities | Buy | Nov 24, 2025 | |
| B. Riley Securities | Buy | $12 | Nov 19, 2025 |
Questions about BTIG and NUVB
- What is BTIG's price target for NUVB?
- BTIG's latest stated price target for Nuvation Bio Inc. (NUVB) is $5, from its action on Mar 26, 2024.
- What is BTIG's rating on NUVB?
- BTIG rates NUVB Buy, a bullish rating, as of Mar 26, 2024.
- When did BTIG last change its view on NUVB?
- On Mar 26, 2024, BTIG upgrades to Buy from Neutral, price target $5.
More NUVB rating histories
All BTIG ratingsNUVB news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.